Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Veradigm Inc. (MDRX)
:MDRX
MDRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.50 - $11.80
Previous CloseN/A
Volume6.73K
Average Volume (3M)746.65K
Market Cap
$905.39M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.34
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding169,549,270
10 Day Avg. Volume228,866
30 Day Avg. Volume746,654
Standard Deviation0.14
R-Squared0.05
Alpha-0.00399
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.39
Price to Cash Flow (P/CF)5.30
P/FCF Ratio7.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$11.00Price Target Upside105.99% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Veradigm News
PremiumCompany Announcements
Veradigm Expands Board with Strategic Appointments
PremiumCompany Announcements
Veradigm Board Restructuring and Strategic Review Updates
---
Ownership Overview
7.57% Insiders
1.75% Mutual Funds
2.08% Other Institutional Investors
88.60% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MDRX FAQ
What was Veradigm Inc.’s price range in the past 12 months?
Veradigm Inc. lowest stock price was $4.50 and its highest was $11.80 in the past 12 months.
What is Veradigm Inc.’s market cap?
Veradigm Inc.’s market cap is $905.39M.
When is Veradigm Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Veradigm Inc.’s earnings last quarter?
Veradigm Inc. released its earnings results on Nov 02, 2023. The company reported $0.215 earnings per share for the quarter, the consensus estimate of $0.215 by $0.
Is Veradigm Inc. overvalued?
According to Wall Street analysts Veradigm Inc.’s price is currently Undervalued.
Does Veradigm Inc. pay dividends?
Veradigm Inc. does not currently pay dividends.
What is Veradigm Inc.’s EPS estimate?
Veradigm Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Veradigm Inc. have?
Veradigm Inc. has 169,549,270 shares outstanding.
What happened to Veradigm Inc.’s price movement after its last earnings report?
Veradigm Inc. reported an EPS of $0.215 in its last earnings report, expectations of $0.215. Following the earnings report the stock price went up 1.329%.
Which hedge fund is a major shareholder of Veradigm Inc.?
Currently, no hedge funds are holding shares in MDRX
---
Veradigm Stock Smart Score
Company Description
Veradigm Inc.
Allscripts Healthcare Solutions, Inc. engages in the provision of clinical, financial, connectivity, information solutions, and related professional services. It operates through the following segments: Clinical and Financial Solutions; Population Health; and Netsmart. The Clinical and Financial Solutions segment involves in the sale of clinical software applications and financial and information solutions. The Population Health segment offers health management and coordinated care solutions. The Netsmart segment operates in the home care and behavioral healthcare information technology field throughout the United States. The company was founded in 1986 and is headquartered in Chicago, IL.
---
MDRX Stock 12 Month Forecast
Average Price Target
$11.00
▲(105.99% Upside)
Technical Analysis
Best Analysts Covering MDRX
1 Year
1 Year Success Rate
17/26 ratings generated profit
1 Year Average Return
+21.84%
reiterated a buy rating 12 months ago
Copying Sean Dodge's trades and holding each position for 1 Year would result in 65.38% of your transactions generating a profit, with an average return of +21.84% per trade.
---